The question isn’t about the timing of the EUA denial. I sold this as soon as they submitted the EUA and haven’t regret it one bit. To me, that was the biggest fraud alert in my head, here’s why:
- They said previously that their trial data was almost done.
- EIND data is not controlled, so there’s no way to say this is even moderately effective
Why submit EUA with no controlled data when your trial results was almost finished? And what happened since they submitted the EUA?
- Patient numbers had to be expanded
- multiple share offerings (first one saying have enough fund to finish trial, then another one being funding themselves for two year. Why fund for two years when you have enough fund to complete the trial and generate revenue with approval? Does that make sense to anyone?)
- Data has been delayed with no news
People tout how this is a safe drug with some 20-30 years history. If it is actually any useful, there should be some trial results with control right? Well there has been zero. That is a huge flag and I’m sure Relief knows it and why they diluted shareholders multiple times before any results came out. My guess is, this trial is going to fail based on past history.
News 
Market Data 
Discover 
AI
